ℹ️
🇬🇧
Search
Search for publications relevant for "free survival"
free survival
Publication
Class
Person
Publication
Programmes
publication
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
2022 |
First Faculty of Medicine
publication
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth
2017 |
First Faculty of Medicine
publication
Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning
2007 |
First Faculty of Medicine
publication
Analysis of advancer NSCLC patients with prolonged progression-free survival after EGFR tyrosine kinase therapy
2011 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Correlation of lymphocyte recovery and progression-free survival after autologous stem cell transplantation in patients with Hodgkin's lymphoma
Publication without faculty affiliation
publication
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
2016 |
Faculty of Medicine in Hradec Králové
publication
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
2014 |
Third Faculty of Medicine
publication
Predictors of complete arrhythmia free survival in patients undergoing surgical ablation for atrial fibrillation. PRAGUE-12 randomized study sub-analysis
2014 |
Third Faculty of Medicine
publication
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
2019 |
Faculty of Medicine in Hradec Králové
publication
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis
2018 |
Second Faculty of Medicine
publication
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
2021 |
Central Library of Charles University
publication
The R-megaCHOP-ESHAP-BEAM study for high-risk aggressive B-cell lymphomas: Patients with early PET negativity have excellent lymphoma-free survival
Publication without faculty affiliation
publication
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
2023 |
Publication without faculty affiliation
publication
Drug resistence proteins and PFS in ovarian cancer patients
2013 |
Faculty of Medicine in Hradec Králové
publication
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
2019 |
Faculty of Medicine in Hradec Králové
publication
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
2021 |
Second Faculty of Medicine
publication
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
2023 |
Publication without faculty affiliation
publication
High-dose Interferon Alpha in Treatment of Patients with Malignant Melanoma, Monitoring of Predictive and Prognostic Biomarkers
2011 |
Faculty of Medicine in Hradec Králové
publication
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
2023 |
Publication without faculty affiliation
publication
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
2010 |
First Faculty of Medicine
publication
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
2023 |
Third Faculty of Medicine
publication
Cabazitaxel in the treatment of a patient with prostate cancer
2020 |
Publication without faculty affiliation
publication
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy
2016 |
First Faculty of Medicine
publication
Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies
2023 |
Faculty of Medicine in Pilsen
publication
Impact of postoperative complications on disease free interval in colorectal cancer after radical surgery
2012 |
First Faculty of Medicine
publication
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma
2018 |
Third Faculty of Medicine
publication
Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population
2019 |
Publication without faculty affiliation
publication
Intensive cyclic chemotherapy and autologous transplantation of peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer follow up at 10 years
2007 |
First Faculty of Medicine
publication
Axtinib in treatment metastatic renal cell carcinoma
2016 |
First Faculty of Medicine
publication
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
2018 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine